Article
APOE Genotype Disclosure Influences Decisions About Future Planning but not Adoption of Healthy Lifestyle Changes in Cognitively Unimpaired Individuals.
Journal of geriatric psychiatry and neurology - 1 Nov 2024
Popescu Dominique L, Lee Athene K, Arthur Edmund, Thompson Louisa I, Alber Jessica
Abstract excerpt
BACKGROUND: Studies have shown apolipoprotein E (APOE) genotype disclosure to be safe and well-tolerated in cognitively unimpaired (CU) older adults. This study aimed to examine the effect of the disclosure process on decisions about future directives and health behaviors in community-dwelling CU older adults from the Butler Alzheimer's Prevention Registry (BAPR). METHODS: CU APOE E4 non-carriers (n = 106) and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
